| Secondary |
| Product Used For Unknown Indication |
50.7% |
| Drug Use For Unknown Indication |
17.2% |
| Mental Disorder |
4.7% |
| Schizophrenia |
4.1% |
| Affective Disorder |
3.2% |
| Psychotic Disorder |
3.2% |
| Anxiety |
2.3% |
| Depression |
2.3% |
| Obsessive-compulsive Disorder |
1.7% |
| Schizophrenia, Paranoid Type |
1.7% |
| Attention Deficit/hyperactivity Disorder |
1.5% |
| Osteogenesis Imperfecta |
1.2% |
| Pain |
1.2% |
| Blood Pressure |
0.9% |
| Parkinson's Disease |
0.9% |
| Smoking Cessation Therapy |
0.9% |
| Contraception |
0.6% |
| Hormone Replacement Therapy |
0.6% |
| Insomnia |
0.6% |
| Sleep Disorder |
0.6% |
|
| Completed Suicide |
15.0% |
| Brain Injury |
8.3% |
| Rhabdomyolysis |
8.3% |
| Suicide Attempt |
6.7% |
| Drug Toxicity |
5.0% |
| Poisoning |
5.0% |
| Respiratory Arrest |
5.0% |
| Sexual Dysfunction |
5.0% |
| Unresponsive To Stimuli |
5.0% |
| Apathy |
3.3% |
| Cognitive Disorder |
3.3% |
| Drug Ineffective |
3.3% |
| Drug Interaction |
3.3% |
| Dysarthria |
3.3% |
| Electrocardiogram Qt Prolonged |
3.3% |
| Intentional Drug Misuse |
3.3% |
| Masked Facies |
3.3% |
| Multiple Drug Overdose |
3.3% |
| Polydipsia |
3.3% |
| Pyrexia |
3.3% |
|
| Concomitant |
| Product Used For Unknown Indication |
21.7% |
| Schizophrenia |
21.4% |
| Drug Use For Unknown Indication |
10.0% |
| Depression |
6.6% |
| Psychotic Disorder |
5.6% |
| Bipolar Disorder |
5.1% |
| Smoking Cessation Therapy |
3.4% |
| Obsessive-compulsive Disorder |
3.2% |
| Bipolar I Disorder |
2.7% |
| Affective Disorder |
2.4% |
| Major Depression |
2.4% |
| Attention Deficit/hyperactivity Disorder |
1.9% |
| Hypertension |
1.9% |
| Insomnia |
1.9% |
| Back Pain |
1.7% |
| Breast Cancer |
1.7% |
| Burkitt's Lymphoma |
1.7% |
| Osteoporosis |
1.7% |
| Alcoholism |
1.5% |
| Anxiety |
1.5% |
|
| Suicide Attempt |
7.8% |
| Weight Increased |
7.8% |
| Death |
7.0% |
| White Blood Cell Count Decreased |
7.0% |
| White Blood Cell Count Increased |
7.0% |
| Suicidal Ideation |
6.2% |
| Hallucination, Auditory |
5.4% |
| Malaise |
5.4% |
| Tachycardia |
5.4% |
| Vomiting |
5.4% |
| Neutropenia |
4.7% |
| Pneumonia |
3.9% |
| Psychotic Disorder |
3.9% |
| Sedation |
3.9% |
| Tardive Dyskinesia |
3.9% |
| Gamma-glutamyltransferase Increased |
3.1% |
| Nausea |
3.1% |
| Overdose |
3.1% |
| Schizophrenia |
3.1% |
| Troponin Increased |
3.1% |
|
| Interacting |
| Product Used For Unknown Indication |
30.0% |
| Tuberculosis Gastrointestinal |
26.7% |
| Tuberculosis Liver |
13.3% |
| Smoking Cessation Therapy |
10.0% |
| Bipolar Disorder |
6.7% |
| Cancer Pain |
6.7% |
| Back Pain |
3.3% |
| Schizophrenia |
3.3% |
|
| Psychotic Disorder |
30.0% |
| Drug Interaction |
10.0% |
| Drug Level Increased |
10.0% |
| Nausea |
10.0% |
| Nightmare |
10.0% |
| Suspiciousness |
10.0% |
| Toxicity To Various Agents |
10.0% |
| Vomiting |
10.0% |
|
